IL7R and RAG1/2 genes mutations/polymorphisms in patients with SCID
Sepideh Safaei1, Zahra Pourpak, Mostafa Moin
1Institute for Genetic Engineering and Biotechnology, Tehran, Iran.
Iranian Journal of Allergy, Asthma, and Immunology
|June 1, 2011
Summary
This study identified 13 mutations in the RAG1, RAG2, and IL7RG genes in patients with severe combined immunodeficiency (SCID) disorder. These genetic mutations are crucial for understanding SCID and developing targeted therapies.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Severe combined immunodeficiency (SCID) is a critical primary failure of the immune system, often stemming from genetic origins.
- Understanding the genetic basis of SCID is essential for accurate diagnosis and effective treatment strategies.
Purpose of the Study:
- To detect mutations in the RAG1, RAG2, and IL7RG genes within a cohort of SCID patients.
- To identify specific genetic variations contributing to SCID disorder.
Main Methods:
- Polymerase Chain Reaction (PCR) sequencing was employed for mutation detection.
- Analysis focused on identifying genetic alterations in key immune system genes.
Main Results:
- A total of 13 mutations were identified across the studied genes.
- Specifically, 4 mutations were found in the IL7RG gene (T661I, I138V, T56A, C57W).
- Seven mutations were identified in the RAG1 gene (W896X, W204R, M324V, T731I, M1006V, K820R, R249H).
- Two mutations were detected in the RAG2 gene (R229W, ΔT251).
Conclusions:
- The study successfully identified multiple mutations in RAG1, RAG2, and IL7RG genes associated with SCID.
- These findings contribute to the genetic landscape of SCID, aiding in the diagnosis and potential therapeutic interventions for affected individuals.
More Related Videos
Related Concept Videos
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...